terminal betDiscussion. This study describes a mechanism by which inhibition of a specific BET bromodomain reduces NOS2 transcription and βA novel, weak bromo and extra terminal domain (BET) bromodomain fragment land to a potent and selective second bromodomain (BD2) inhibitor.